Global Cell Expansion Market

Cell Expansion Market Size, Share, Growth Analysis, By Product(Consumables, Culture Flasks & Accessories, Instruments), By Cell Type(Mammalian, Microbial, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35J2071 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 77

Cell Expansion Market Regional Insights

With a share of 43.1% in 2023, North America had the greatest proportion. Due to increased government funding initiatives that have sped up the development of regenerative medicine and cellular therapy products as well as the production of stem cells, the region will maintain its leadership position over the future years. As a result, there is a demand for cell expansion platforms in this area. For instance, the FDA and the Medical Technology Enterprise Consortium (MTEC) gave the Southwest Research Institute (SwRI) (U.S.) a total of USD 5.3 million in financing. In order to grow cells for the creation of individualized regenerative medicine, the SwRI invested these monies. The revenue generation in this area is increased by such investments.

Asia Pacific is anticipated to see the quickest growth throughout the forecast period as a result of increased efforts made by numerous local pharmaceutical and biotechnology businesses to develop and market their cellular medicines. For the purpose of commercializing its Stempeucel stem cell-based product, an Indian business by the name of Stempeutics Research Pvt. Ltd. struck an association with Kemwell Biopharma.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cell Expansion Market size was valued at USD 25.21 billion in 2022 and is poised to grow from USD 27.60 billion in 2023 to USD 57.06 billion by 2031, growing at a CAGR of 9.5% during the forecast period (2024-2031). 

The cell expression market is highly competitive and consists of several key players. These players engage in strategies such as collaborations, partnerships, mergers and acquisitions, and product launches to gain a competitive edge. 'Thermo Fisher Scientific Inc. (United States)', 'Merck KGaA (Germany)', 'Lonza Group Ltd. (Switzerland)', 'GE Healthcare (United States)', 'Sartorius AG (Germany)', 'Promega Corporation (United States)', 'Agilent Technologies, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Eppendorf AG (Germany)', 'Takara Bio Inc. (Japan)', 'GenScript Biotech Corporation (China)', 'CellGenix GmbH (Germany)', 'BD Biosciences (United States)', 'Novasep Holding S.A.S. (France)', 'OriGene Technologies, Inc. (United States)', 'Lonza Biologics Plc (United Kingdom)', 'Danaher Corporation (United States)', 'Wuxi AppTec Co., Ltd. (China)', 'Charles River Laboratories International, Inc. (United States)', 'Miltenyi Biotec GmbH (Germany)', 'New England Biolabs, Inc. (United States)', 'Qiagen N.V. (Netherlands)'

The continuous advancements in genetic engineering technologies, such as CRISPR/Cas9, have facilitated the development of high-performing cell lines for protein expression. These technologies enable precise modification of cell genomes to enhance protein production, optimize cellular pathways, and improve product quality. The availability of well-characterized and highly productive cell lines contributes to the growth of the cell expression market.

Researchers and scientists are exploring and developing novel expression systems to overcome the limitations of traditional platforms. For instance, cell-free expression systems, including cell-free protein synthesis (CFPS), are gaining attention due to their ability to produce proteins without the need for intact cells. Additionally, synthetic biology approaches are being employed to engineer cell lines with enhanced expression capabilities and more efficient protein production.

With a share of 43.1% in 2023, North America had the greatest proportion. Due to increased government funding initiatives that have sped up the development of regenerative medicine and cellular therapy products as well as the production of stem cells, the region will maintain its leadership position over the future years. As a result, there is a demand for cell expansion platforms in this area. For instance, the FDA and the Medical Technology Enterprise Consortium (MTEC) gave the Southwest Research Institute (SwRI) (U.S.) a total of USD 5.3 million in financing. In order to grow cells for the creation of individualized regenerative medicine, the SwRI invested these monies. The revenue generation in this area is increased by such investments.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Tissue Expanders Market
Buy Now GET FREE SAMPLE
3D Cell Culture Market
Buy Now GET FREE SAMPLE
Cell Lysis Market
Buy Now GET FREE SAMPLE
Cell Therapy Market
Buy Now GET FREE SAMPLE
Cell-Based Assays Market
Buy Now GET FREE SAMPLE
Single Cell Analysis Market
Buy Now GET FREE SAMPLE
Cell Culture Media Market
Buy Now GET FREE SAMPLE
Cell Isolation/Cell Separation Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Cell Expansion Market

Report ID: SQMIG35J2071

$5,300
BUY NOW GET FREE SAMPLE